Foscarnet-Ganciclovir CMV
Retinitis Trial (FGCRT)
1. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Studies of Ocular Complications
of AIDS Foscarnet-Ganciclovir
Cytomegalovirus Retinitis Trial:
1. Rationale, design, and
methods. Controlled Clin Trials.
1992;13:22-39. PMID:
1315661
2. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Mortality in patients with the
acquired immunodeficiency
syndrome treated with either foscarnet or ganciclovir for
cytomegalovirus retinitis. New
Eng J Med. 1992;326:213-220.
PMID: 1345799
3. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group. Foscarnet-Ganciclovir CMV
Retinitis Trial: 4. Visual
outcomes. Ophthalmology.
1994;101:1250-1261. PMID:
8035989
4. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Morbidity and toxic effects
associated with ganciclovir or
foscarnet therapy in a
randomized cytomegalovirus
retinitis trial. Arch Int Med
1995;155:65-74. PMID:
7802522
5. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with AIDS
Clinical Trials Group. Antiviral
effects of foscarnet and
ganciclovir therapy on human
immunodeficiency virus p24
antigen in patients with AIDS
and cytomegalovirus retinitis.
J
Infect Dis. 1995;172:613-621.
PMID: 7658051
6. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Assessment of cytomegalovirus
retinitis: clinical evaluation vs centralized grading of fundus
photographs. Arch Ophthalmol.
1996;114:791-805. PMID:
8660161
7. Wu AW, Coleson LC, Holbrook
JT, Jabs DA; for the Studies of
Ocular Complication of AIDS
Research Group. Measuring visual
function and quality of life in
patients with cytomegalovirus
retinitis: Development of a
questionnaire. Arch Ophthalmol.
1996;114:841-847. PMID:
8660168
8. Studies of the Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Clinical vs. photographic
assessment of treatment of
cytomegalovirus retinitis. Foscarnet-Ganciclovir
Cytomegalovirus Retinitis Trial
Report 8. Arch Ophthalmol.
1996;114:848-855. PMID:
8660169
9. Studies of Ocular
Complications of AIDS; in
collaboration with the AIDS
Clinical Trials Group.
Cytomegalovirus (CMV) culture
results, drug resistance, and
clinical outcome in patients
with AIDS and CMV retinitis
treated with foscarnet or
ganciclovir. J Infect Dis.
1997;176:50-58. PMID:
9207349
10. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group. Rhegmatogenous retinal
detachment in patients with
cytomegalovirus retinitis: The
Foscarent-Ganciclovir
Cytomegalovirus Retinitis Trial.
Am J Ophthalmol.
1997;124:61-70. PMID:
9222234
11. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group. Foscarnet-Ganciclovir
Cytomegalovirus Retinitis Trial:
5. Clinical features of
cytomegalovirus retinitis at
diagnosis. Am J Ophthalmol.
1997;124:141-157. PMID: 9262538
12. Wu AW, Revicki DA, Jacobson
D, Malitz FE. Evidence for
reliability, validity and
usefulness of the Medical
Outcomes Study HIV Health Survey
(MOS-HIV). Quality of Life Res.
1997;6: 481-493. PMID:
9330549
13. Holbrook JT, Davis MD,
Hubbard LD, Martin BK, Holland
GN, Jabs DA, Gilpin AK, Meinert
CL and Reshef DS; for the Studies
of Ocular Complications of AIDS
Research Group. Risk factors for
advancement of cytomegalovirus
retinitis in patients with AIDS.
Arch Ophthalmol.
2000;118:1196-1204. PMID: 10980764
Back
to top
of page
CMV Retinitis Retreatment Trial (CRRT)
1. Studies of the Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Combination foscarnet and
ganciclovir therapy vs.
monotherapy for the treatment of
relapsed cytomegalovirus
retinitis in patients with AIDS:
The Cytomegalovirus Retreatment
Trial. Arch Ophthalmol.
1996;114: 23-33. PMID:
8540847
2. Martin BK, Gilpin AMK, Jabs
DA, and Wu AW; for the Studies of
Ocular Complications of AIDS
Research Group. Reliability,
validity, and responsiveness of
general and disease-specific
quality of life measures in a
clinical trial for
cytomegalovirus retinitis. J Clin Epidemiol.
2001;54:376-386.
PMID: 11305288 Back
to top
of page
HPMPC Peripheral CMV Retinitis
Trial (HPCRT)
1. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group. Parenteral cidofovir for
cytomegalovirus retinitis in
patients with AIDS: The HPMPC
Peripheral Cytomegalovirus
Retinitis Trial. A randomized,
controlled trial. Ann Intern Med.
1997;126:264-274. PMID:
9036798
2. Jabs DA, Meinert CL, Lalezari
JP. Letter to the Editor
(response) regarding cidofovir
for cytomegalovirus retinitis (HPCRT).
Ann Int Med. 1997;127:490-491.
3. The Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
Long-term follow-up of patients
with AIDS treated with parenteral cidofovir for
cytomegalovirus retinitis: The
HPMPC Peripheral Cytomegalovirus
Retinitis Trial. AIDS.
2000;14:1571-1581.
PMID: 10983644 Back
to
top
of page
Monoclonal Antibody CMV Retinitis
Trial (MACRT)
1. Studies of Ocular
Complications of AIDS Research
Group; in collaboration with the
AIDS Clinical Trials Group.
MSL-109 adjuvant therapy for
cytomegalovirus retinitis in
patients with acquired
immunodeficiency syndrome: The
Monoclonal Antibody
Cytomegalovirus Retinitis Trial.
Arch Ophthalmol.
1997;115:1528-1536. PMID: 9400786
2. Jabs DA, Kaplan Gilpin AM,
Min YI, Erice A, Kempen JH and
Quinn TC; for the Studies of
Ocular Complications of AIDS
Research Group. HIV and CMV
viral load and clinical outcomes
in patients with AIDS and
cytomegalovirus retinitis: The
Monoclonal Antibody
Cytomegalovirus Retinitis Trial.
AIDS. 2002;16: 877-887.
PMID: 12232843
3. Davidson M, Min Y, Holbrook
JT, Quinn T, Murphy R, Jabs DA,
Jacobson M, and Meinert CL; for
the Studies of Ocular
Complications of AIDS Research
Group. The Influence of filgrastim (granulocyte
colony-stimulating factor on
human immunodeficiency virus
type 1 RNA in patients with
cytopmegalovirus retinitis. J Inf Dis.
2002;186:1013-8. PMID: 12232843
4. Gilpin AM, Holbrook JT, Jabs
DA, Meinert CL; for the Studies
of Ocular Complications of AIDS
Research Group. Data and safety
monitoring board deliberations
resulting in the early
termination of the Monoclonal
Antibody Cytomegalovirus
Retinitis Trial. Controlled
Clinical Trials.
2003;24(1):92-98.
PMID: 12559647
Back to
TOP
of page
Ganciclovir Cidofovir CMV
Retinitis Trial (GCCRT)
1. The Studies of Ocular
Complications of AIDS Research
Group (SOCA); in collaboration
with the AIDS Clinical Trials
Group. The ganciclovir implant
plus oral ganciclovir versus
parenteral cidofovir for the
treatment of cytomegalovirus
retinitis in patients with
acquired immunodeficiency
syndrome: The Ganciclovir
Cidofovir CMV Retinitis Trial.
Am J Ophthalmol.
2001;131:457-467. PMID: 11292409
2. Dunn JP, Van Natta ML,
Foster G, Kuppermann B, Martin DF, Zong A,
and Jabs DA; for the
Studies of Ocular Complications
of AIDS Research Group.
Complications of Ganciclovir
implant surgery in patients with
CMV retinitis. Retina 24
(1): 41-50, 2004.
PMID: 15076943
Back to
TOP
of page
Longitudinal Study of Ocular
Complications of AIDS (LSOCA)
1. Jabs DA, Van Natta ML, Kempen
JH, Pavan PR, Lim J, Murphy R,
Hubbard L; for the Studies of
Ocular Complications of AIDS
Research Group. Characteristics
of patients with CMV retinitis
in the era of highly active
anti-retroviral therapy (HAART).
Am J Ophthalmol.
2002;133: 48-61. PMID: 11755839
2. Kempen JH, Martin BK, Wu A,
Barron B, Thorne JE, Jabs DA; for
the Studies of Ocular
Complications of AIDS Research
Group. The effect of
cytomegalovirus retinitis on the
quality of life of patients with
acquired immune deficiency
syndrome in the era of highly
active anti-retroviral therapy.
Ophthalmology. 2003;110
(5).
PMID: 12750102
3. Marshall BC, Jacobson MA,
Adler SP; in collaboration with
the Studies of Ocular
Complications of AIDS Research
Group. Avidity of Antibodies to
Cytomegalovirus in HIV Seropositive Patients with and
without CMV Retinitis. Viral Immunol.
2004;17(1):101-8. PMID: 15018666
4. Jacobson MA, Maecker HT, Orr
PL, D'Amico R, Van Natta M, Li
XD, Pollard RB, Bredt BM; for the
Adults AIDS Clinical Trials
Group and the Studies of Ocular
Complications of AIDS Research
Group. Results of a CMV-Specific CD8+/IFNγ+Cytokine
flow cytometry assay correlate
with clinical evidence of
protective immunity in AIDS
patients with CMV retinitis. J Infect Dis.
2004;189: 1362-1373.
PMID: 15073672
5. Jabs DA, Van Natta ML,
Thorne JE, Weinberg DV
Meredith TA, Kuppermann BD,
Sepkowitz K, Li HK; for the
Studies of Ocular
Complications of AIDS
Research Group. Course of
cytomegalovirus retinitis in
the era of highly active
antiretroviral therapy: 1.
Retinitis progression.
Ophthalmology. 2004;111:
2224-2231.
PMID: 15582078
6. Jabs DA, Van Natta ML,
Thorne JE, Weinberg DV,
Meredith TA, Kuppermann BD,
Sepkowitz K, Li HK; for the
Studies of Ocular
Complications of AIDS
Research Group. Course of
cytomegalovirus retinitis in
the era of highly active antiretorviral therapy: 2.
Second eye involvement and
retinal detachment. Ophthalmology.
2004;111:
2232-2239.
PMID: 15582079
7. Weinberg DV, Holbrook JT,
Hubbard LD, Davis MD, Jabs
DA, Holland GN; for the
Studies of Ocular
Complications of AIDS
Research Group. Clinician
versus Reading Center
Assessment of
cytomegalovirus retinitis
lesion size. Ophthalmology.
2005;112: 559-566.
PMID: 15808244
8. Jabs DA, Holbrook JT, Van
Natta ML, Clark R, Jacobson
MA, Kempen JH, Murphy RL; for
the Studies of Ocular
Complications of AIDS
Research Group. Risk Factors
for Mortality in Patients
with AIDS in the era of
HAART. Ophthalmology.
2005;112:771-779.
PMID: 15878056
9. Semba RD, Martin BK, Kempen
JH, Thorne JE, Wu AW. Ocular
Complications of AIDS Research
Group. The impact of anemia on
energy and physical functioning
in individuals with AIDS. Arch
Intern Med. 2005;24,165 (19):2229-2236.
PMID: 16246988
10. Kempen JH, Min Y-I, Freeman
WR, Holland GN, Friedberg DN,
Dieterich DT, Jabs DA; for the
Studies of Ocular Complications
of AIDS Research Group. Risk of
immune recovery uveitis in
patients with AIDS and
cytomegalovirus retinitis. Ophthalmology.
2006;113(4):684-694. PMID:
16581429
11. Brown DM,
Thorne JE, Foster GL, Duncan JL, Brune LM, Mũnana A,
Meinert CL, Jabs DA; for the Studies of Ocular
Complications of AIDS Research
Group. Factors affecting
attrition of patients with AIDS.
AIDS Care. 2006;18(7):821-829.
PMID: 16971294
12.
Thorne JE,
Jabs DA, Kempen JH, Holbrook JT,
Nichols C, Meinert CL;
for the
Studies of Ocular Complications
of AIDS (SOCA) Research Group. Incidence of and
risk factors for visual acuity
loss among patients with AIDS
and cytomegalovirus (CMV) retinitis in the era of
highly active antiretroviral
therapy. Ophthalmology.
2006;113(8):1432-40.
PMID: 16766032
13. Thorne JE,
Jabs DA, Kempen JH, Holbrook JT,
Nichols C, Meinert CL; for the
Studies of Ocular Complications
of AIDS (SOCA) Research Group. Causes of visual
acuity loss among patients with
AIDS and CMV in the era of HAART.
Ophthalmology. 2006;113:1441-1445.
PMID:
16781775
14. Shah KH,
Holland GH, Yu F, Van Natta M,
Nusinowitz S; in collaboration
with the Studies of Ocular
complications of AIDS (SOCA)
Research Group. Contrast
sensitivity and color vision in
HIV-infected individuals without
infectious retinopathy. Am J
Ophthalmol. 2006;142:
284-292.
PMID:
16876510
15. Sinclair E,
Tan QX, Sharp M, Girling V, Poon
C, Van Natta ML, Jabs DA,
Inokuma M, Maecker HT, Bredt B,
Jacobson MA; Studies of Ocular
Complications of AIDS Research
Group. Protective immunity to
cytomegalovirus (CMV) retinitis
in AIDS is associated with
CMV-specific T cells that
express interferon-gamma and
interleukin-2 and have a CD8+
cell early maturation phenotype.
J Infect Dis. 12006;94(11):1537-46.
PMID:
17083038
16. Thorne JE, Holbrook JT, Jabs
DA, Kempen JH, Nichols C,
Meinert CL; for the Ocular
Complications of AIDS Research
Group. The effect of
cytomegalovirus (CMV) retinitis
on the risk of visual acuity
loss among patients with AIDS.
Ophthalmology.
2007;114:591-598.
PMID: 17123624
17.
Jabs
DA, Van Natta ML, Holbrook JT,
Kempen JH, Meinert CL, Davis MD;
for the Studies of the Ocular
Complications of AIDS Research
Group. The Longitudinal Study of
the Ocular Complications of
AIDS: 1. Ocular diagnoses at
enrollment. Ophthalmology.
2007;114:780-786. PMID: 17258320
18.
Jabs DA, Van
Natta ML, Holbrook JT, Kempen JH,
Meinert CL, Davis MD; for the
Studies of the Ocular
Complications of AIDS Research
Group. The Longitudinal Study of
the Ocular Complications of
AIDS: 2. Ocular examination
results at enrollment. Ophthalmology.
2007;114:787-793. PMID: 17210182
19. Jacobson,
MA, Tan QX, Girling V. Poon C,
Van Natta ML, Jabs DA, Inokuma
M, Maecker HT, Bredt B, and
Sinclair E; for the Studies of
Ocular Complications of AIDS
Research Group. Poor predictive
value of cytomegalovirus (CMV)-specific
T cell assays for the
development of CMV retinitis in
patients with AIDS. Clin
Infect Dis. 2008;46:458-466.
PMC: 2666016
20. Freeman
WR, Van Natta ML, Jabs DA,
Sample PA, Sadun AA, Thorne J,
Shah KH, Holland GN; for the SOCA
Research Group. Vision function
in HIV-infected individuals
without retinitis: Report of the
Studies of Ocular Complications
of AIDS Research Group. Am J
Ophthalmol. 2008;45:453-462.
PMC: 2959724
21. Jabs DA;
for the Studies of Ocular
Complications of AIDS Research
Group. AIDS and ophthalmology.
Arch Ophthalmol.
2008;126:1143-1146. PMID:
18695113
22. Holland
GN, Kappel PJ, Van Natta ML,
Palella FJ, Lyon AT, Shah KH,
Pavan PR, Jabs DA; on behalf of
the Studies of the Ocular
Complications of AIDS Research
Group. Association between
abnormal contrast sensitivity
and mortality among people with
acquired immunodeficiency
syndrome. Am J Ophthalmol.
2010;149:807-816. PMID: 20399927
23.
Hendrickson SL,
Jabs DA, Van Natta M, Lewis RA,
Wallace DC, O'Brien SJ.
Mitochondrial haplogroups are
associated with risk of
neuroretinal disorder in
HIV-positive patients. J Acquir Immune Defic Syndr.
2010;53: 451-455. PMID: 20098332
24.
Sezgin E, Jabs
DA, Hendrickson SL, Van Natta M,
Zdanov A, Lewis RA, Smith MW,
Troyer JL, O’Brien SJ; for the
SOCA Research Group. Effect of
host genetics on CMV retinitis
occurrence in patients with
AIDS. J Infect Dis. 2010;202:606-613.
PMC: 2932829
25.
Sezgin E,
Hendrickson SL, Jabs DA, Van
Natta M, Lewis RA, Troyer JL,
O’Brien SJ; for the SOCA Research
Group. Effect of host genetics on
incidence of HIV neuroretinal
disorder in patients with AIDS.
J Acquir Immune Defic Syndr.
2010;54:343-351. PMC: 2908809
26.
Puhan M,
Van Natta ML, Pallela FJ,
Addessi A, Meinert CL. Excess
mortality in patients with AIDS
in the era of highly active
antiretroviral therapy: Temporal
changes and risk factors. Clin
Inf Dis. 2010;51:947–956.
PMC: 2943970
27.
Jabs DA, Ahuja A, Van Natta M,
Lyon A, Srivastava S, Gangaputra
S; for the Studies of the Ocular
Complications of AIDS Research
Group.
Course of Cytomegalovirus
Retinitis in the Era of Highly
Active Antiretroviral Therapy:
Five-year Outcomes. Ophthalmology,
2010;117(11):
2152-61.
PMC: 2963687
28.
Thorne J, Van
Natta ML, Jabs DA, Duncan J,
Srivastava S; for the Studies of
the Ocular Complications of AIDS
Research Group. Visual field loss
among patients with
cytomegalovirus retinitis.
Ophthalmology.
2011;118:895-901. PMC: 3087851
29.
Sezgin E,
Van Natta M, Ahuja A, Lyon A,
Srivastava S, Troyer JL, O’Brien SJ, Jabs
DA; for the SOCA Research
Group.
Association of
Host Genetic Risk
Factors with the Course
of Cytomegalovirus Retinitis in
Patients Infected with HIV. Am J Ophthalmol.
2011;151:999-1006. PMC:
3103625
30. Holbrook JT, Colvin R, Van
Natta ML, Thorne JE, Bardsley M,
Jabs DA; for the Studies of
Ocular Complications of AIDS (SOCA)
Research Group. Evaluation of
the United States Public Health
Service guidelines for
discontinuation of
anti-cytomegalovirus therapy
after immune recovery in
patients with CMV retinitis.
Am J Opthalmol
2011;154(4):628-637. PMC:
3185165
31. Puhan M, Ahuja A, Van Natta
ML, Ackatz LE, Meinert CL; for
the Studies of Ocular
Complications of AIDS Research
Group. Interviewer versus
self-administered health-related
quality of life questionnaires -
Does it matter? HQLO
2011;9:30. PMC: 3100232
32. Gangaputra S, Won Pak J,
Peng Q, Hubbard LD, Thayer D,
Krason Z, Joyce J, Danis RP; for
the Studies of Ocular
Complications of AIDS Research
Group. Transition from film to
digital fundus photography in
the Longitudinal Studies of
Ocular Complications of AIDS.
Retina
2012;32:600-605.
PMID: 21857393
33. Gangaputra S, Kalyani PS,
Fawzi AA, Van Natta ML, Hubbard
LD, Danis RP, Thorne JE, Holland
GN; on behalf of the
Studies of Ocular Complications
of AIDS Research Group. Retinal
vessel caliber among people with
AIDS: Relationship with
disease-associated factors and
mortality. Am J Ophthalmol
2012;153:434-444. PMC: 3289046
34. Kalyani PS, Fawzi AA,
Gangaputra S, Van Natta ML,
Hubbard LD, Danis RP, Thorne JE,
Holland GN; on behalf of the
Studies of Ocular Complications
of AIDS Research Group.
Retinal vessel caliber among
people with AIDS: Relationships
with visual function. Am J Ophthalmol
2012;153:428-433. PMID:
22019221
35. Sugar EA, Jabs DA, Ahuja A,
Thorne JE, Danis RP, Meinert CL;
for the Studies of Ocular
Complications of AIDS Research
Group. Incidence of
cytomegalovirus retinitis in the
era of highly active
antiretrovial therapy. Am J Ophthalmol
2012;153:1016-1024. PMC: 3358595
36. Limou S, Delameau O, van Manen D, An P, Sezgin E, Le
Clerc S, et al. Multicohort
genomewide association study
reveals a new signal of
protection against HIV-1
acquistion. J Infect Dis
2012;205:1155-1162. PMC:
3295605
37. Kalyani PS, Holland GN,
Fawzi AA, Arantes TEF, Sadun AA;
in collaboration with the
Studies of Ocular Complication
of AIDS Research Group.
Association between retinal
nerve fiber layer thickness and
abnormalities of vision in
people with human
immunodeficiency virus
infection. Am J Ophthalmol
2012;153(4):734-742. PMID:
222454559
38. Branch AD, Van Natta ML,
Vachon ML, Dieterich DT, Meinert
LC, Jabs DA; for the Studies of
Ocular Complications of AIDS
Research Group. Mortality
in HCV-infected patients with a
diagnosis of AIDS in the era of
combination anti-retroviral
therapy. Clin Infect
Dis 2012;55(1):137-144. PMC:
336965
39. Kempen JH, Sugar EA, Lyon
AT, Lewis RA, Jabs DA, Heinemann
MH, Dunn JP for the Studies of
Ocular Complications of AIDS.
Risk of cataract in persons with
cytomegalovirus retinitis and
the acquired immune deficiency
syndrome. Ophthalmology
2012; 119:2343-2350. PMID:
22853972
40. Althoff K, Buchacz K, Hall
IH, Zhang J, Hanna DB, Rebeiro
P, Gange SJ, Moore RD, Kitahata
MM, Gebo KA, Martin J, Justice
AC, Horberg MA, Hogg RS,
Sterling TR, Cescon A, Klein MV,
Thorne JE, Crane HM, Gugavero MJ,
Napravnik S, Kirk GD, Jacobson
LP, Brooks JT for the North
American AIDS Cohort
Collaboration on Resarch and
Design. US Trends in
antiretroviral therapy use, HIV
RNA plasma viral loads, and CD4
T-Lymphocyte cell counts among
HIV-infected persons.
Ann Intern Med 2012;
157:325-335. PMID: 22944874
41. Gangaputra S, Drye L, Vaidya
V, Thorne JE, Jabs DA, Lyon A
for the Studies of the Ocular
Complications of AIDS Research
Group. Non-cytomegalovirus
ocular opportunistic infections
in patients with AIDS.
Am J Ophthalmol 2013;
155(2):206-212. PMID: 23068916
42, Jabs DA, Ajuja A, Van Natta
ML, Dunn JP, Yeh S for the
Studies of Ocular Complications
of AIDS Research Group.
Comparison of treatment regimens
for cytomegalovirus retinitis in
patients with AIDS in the era of
highly active antiretroviral
therapy. Ophthalmology
Feb 2013, in press.
43. Krauskopf K, Van Natta ML,
Danis RP, Gangaputra S, Federman
AD, Branch AD, Meinert CL, Jabs
DA for the Studies of Ocular
Complications of AIDS Research
Group. Correlates of
hypertension in patients with
AIDS in the era of highly active
antiretroviral therapy.
JIAPAC, 15Apr2013, (accepted).
Back to
TOP
of page
Studies of
Ocular Complications of AIDS (SOCA)
1. Holbrook JT, Meinert CL, Van
Natta ML, Davis MD, Hubbard L,
Jabs DA; for the Studies of
Ocular Complications of AIDS
Research Group. Photographic
measures of cytomegalovirus
retinitis as surrogates for
visual outcomes in treated
patients. Arch Ophthalmol.
2001;119:554-563. PMID: 11296021
2. Holbrook JT, Meinert CL, Jabs
DA; for the Studies of Ocular
Complications of AIDS Research
Group. Patient notification and followup after suspension of
treatment protocols: Experience
from four clinical trials of
treatments for AIDS-related CMV
Retinitis. Controlled Clin
Trials. 2002;22:62-68. PMID:
11165425
3. Davidson M, Min Y, Holbrook
JT, Van Natta ML, Murphy R, Jabs
DA, Welch W, and Meinert CL; for
the Studies of Ocular
Complications of AIDS Research
Group. Use of filgrastim (G-CSF)
as adjuvant therapy in patients
with AIDS-related
cytomegalovirus retinitis. AIDS.
2002;16: 757-765. PMID: 11964532
4. Holbrook JT, Jabs DA, Lewis
RA, Weinberg D, Davis MD,
Friedberg D; for the Studies of
Ocular Complications of AIDS
Research Group. Visual loss in
patients with cytomegalovirus
retinitis and AIDS before wide
spread availability of highly
active antiretroviral therapy.
Arch Ophthalmol. 2003;121(1):99-107.
PMID: 12523893
Back to
TOP
of page
Other
Publications
These
books are available at
http://www.amazon.com
Clinical
Trials Dictionary: Terminology and Usage
Recommendations. Meinert, CL.
Baltimore, MD, 1996.
Clinical
Trials: Design, Conduct, and Analysis.
Meinert, CL. New York, 1986.
Clinical
Trials: A Methodologic Perspective.
Piantadosi, S. New York, 1997.
Clinical Trials: An Insider's
Guide to Clinical Trials. Meinert,
CL. Oxford University Press,
2011.
Back to
TOP
of page
|